Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Dose Range: 100300 mcg of each peptide daily with gradual titration
decades of cosmetic and wound-healing literature No multi-center RCT BPC-157: Limited, Emerging Clinical Evidence 100+ preclinical repair studies Human evidence is thin but real PL-14736 (its clinical-development name) reached abstract-level Phase 1/2 in ulcerative colitis A modern hamstring tendon Phase 2 RCT is recruiting, and an intra-articular knee case series exists Clean early-phase safety
Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications
Response: We appreciate the overwhelming support for CMS price transparency policies, which include HPT, TiC, and the implementation of the No Surprises Act (NSA)
Discontinue use and consult your doctor If any adverse reactions occur
